Drug use, public health, health services, epidemiology, & harm reduction researcher. Partner, parent, friend, & biker. Tweets my opinions, not others'.
Joined July 2020
- Tweets252
- Following191
- Followers223
- Likes224
Read about Spokane's Community Drug Checking Program which we are collaborating on.
NEW: Caleb @BantaGreen (ADAI/@UWPsychiatry) talks to @SpokesmanReview about a statewide community drug-checking network helping people find out what's really in their drugs, as well as informing public health folks about the drug supply in our state: spokesman.com/stories/2024/f…
Please join me this Friday at Grand Rounds as I share the why and how of our Center for Community-Engaged Drug Education, Epidemiology & Research @adai_uw @UWPsychiatry @uwsph @WADeptHealth @WSMA_update @WA_Health_Care
2/26 Grand Rounds. Dr. Caleb Banta-Green @adai_uw will provide an overview of the new Center for Community-Engaged Drug Education, Epidemiology & Research (CEDEER) housed within the Addictions, Drug and Alcohol Institute (ADAI). tinyurl.com/26ae7pmr
Caleb Banta-Green retweeted
🎶Looks like we maaade it!🎶Our first "Tweet of the Week" in the @UWPsychiatry newsletter! Woooo, congrats, us!
While you're celebrating our awesome achievement, don't forget to register for Dr. @BantaGreen's upcoming Grand Rounds! Info: adai.uw.edu/webinar-psychiat…
ALT Screenshot from the UW Psychiatry newsletter showing "Tweet of the Week" and our tweet about an upcoming Psychiatry Grand Rounds webinar featuring ADAI's Caleb Banta-Green talking about his Center for Community-Engaged Drug Education, Epidemiology & Research in WA State
Caleb Banta-Green retweeted
ADAI/@UWPsychiatry's Caleb @BantaGreen is mentioned in this piece about Canada's Rapid Access Addiction Medicine (RAAM) clinics, similar to the "health engagement hubs" Dr. Banta-Green has advocated for in WA to provide low-barrier access to services for people who use drugs.
"That makes the RAAM program a win-win: It provides a better health outcome for the patients, while better utilizing health care facilities."
southseattleemerald.com/2023…
Exciting new work we are happy to be partnering on #HarmReduction #DrugChecking @WADeptHealth @KCPubHealth @wa_health_care
#DrugChecking services - testing to see what chemicals are in a sample - help people who use drugs make better-informed decisions about their drug use & reduce risks to their health.
Learn more in our new ADAI Brief and companion webinar on Dec. 5th! adai.uw.edu/drug-checking-br…
ALT NEW ADAI REPORT: The Use and Impact of Community Drug Checking Services. See also: Companion webinar, Dec 5, 10am PT. Companion website: Drug Checking Results in WA State. Find all at adai.uw.edu/drug-checking-brief
Caleb Banta-Green retweeted
Great summary from @MLBaruchman about last weeks' expert panel on fentanyl in King County, featuring ADAI/@UWPsychiatry's Caleb @BantaGreen.
Learn more about fentanyl, overdose, and treatment options for opioid use disorder at StopOverdose.org and LearnAboutTreatment.org
In a live, public event, The Seattle Times gathered local experts to share more about the fentanyl epidemic, including treatment options and how policymakers should respond. st.news/471woIz
See you there!
You do not want to miss @seattletimes live event TONIGHT, where a community panel of experts will delve into fentanyl and opioids research, treatment and potential solutions! @ADAI_UW’s Caleb @BantaGreen will be one of tonight’s speakers.
FREE Sign UP: hiprc.org/blog/fentanyl-in-k…
#Naloxone updates from our great colleagues, join us!
Got questions about #naloxone?
Get answers on October 24 from the ADAI CEDEER team & presenters from @WADeptHealth and @HealthNYGov!
Topics will include: new products, dosing guidelines, and the latest info on overdose response. Register: washington.zoom.us/webinar/r…
ALT Naloxone vial with text overlayed that reads What's New with Naloxone? ADAI/UW webinar: October 24, 2023 | 2-3pm PT
Caleb Banta-Green retweeted
Join ADAI/@UWPsychiatry's Mandy Owens & team TOMORROW to hear about their project bringing together diverse community members in 3 counties across Washington to develop strategies for improving interactions between police & people who use drugs. Register: washington.zoom.us/meeting/r…
ALT ADAI webinar: Community-Law Enforcement Aligning in Response to Substance use (CLEARS Project): An Alternative to Bringing Together Diverse Stakeholders. Join us Oct. 3, 2023 | 1-2pm PT. "Project brings together diverse stakeholders in a policy codesign process to develop regional strategies to improve interactions between law enforcement and people who use drugs" - PI Dr. Mandy Owens
Meds for opioid use disorder (OUD) are *the* evidence based intervention, including for youth. But families don't know it and most peds/adol/family docs don't offer meds. seattletimes.com/seattle-new…
In my conversations with providers they say that when they began treating OUD with meds they realized it was one of the most impactful, life saving, and rewarding things they'd done in medicine. @uwmnewsroom @wa_he @wsma @seattlechildren
Info about #fentanyl use, #overdose, and potential #addiction for caregivers/parents @hiprc in multiple languages
If your child is using fentanyl, they could quickly develop an addiction. You play an important role in keeping them safe. Talk to them today about avoiding opioids like #fentanyl.
hiprc.org/opioids
ALT Flier from UW HIPRC with a checklist on how to talk to kids about fentanyl. Flier translated in Spanish, Vietnamese, and Russian.
A thoughtful letter for WA State health cabinet secretaries and me thanking harm reduction, health care, & Tx service providers. We also offer opportunities for all community members to engage in concrete activities to help people using fentanyl & those addicted to fentanyl.
In this letter for #NationalOpioidAwarenessDay, ADAI/@UWPsychiatry's Dr. @BantaGreen & colleagues name 3 priorities for saving lives from overdose: 1) treatment medications (buprenorphine, e.g.), 2) naloxone access, & 3) building awareness/reducing stigma: hca.wa.gov/assets/program/op…
ALT Purple ribbon with text National Opioid Awareness Day September 21
2023 is on track to be a devastating year for overdose deaths. “Naloxone is necessary but completely inadequate,” says ADAI/@UWPsychiatry’s Caleb @BantaGreen. Meds like buprenorphine & methadone are key to reducing deaths & supporting long-term recovery. cnn.com/2023/09/13/health/ov…
This letter from Poison Center directors of Oregon and Washington provides a clear summary of "what does this mean to me" for the findings that residue of drugs were found on some buses and trains. @MRYUKWA @ORpoisoncenter
This Post is from an account that no longer exists. Learn more
How #HarmReduction services work is beautifully described by Joe Tinsley with @KCPubHealth in this piece by @KateWaltersKUOW for @KUOW
Caleb Banta-Green (@BantaGreen) strongly advocates for expanding harm-reduction service centers and giving them the supplies they need to engage with people struggling with addiction to #fentanyl and other opioids. tinyurl.com/496kht93 @adai_uw @UWPsychiatry
Our #CEDEER team is honored to be a trusted source sharing evidence based info during the ongoing interest in many drug related issues. adai.uw.edu/cedeer/
ADAI/@UWPsychiatry staff and faculty have been in the news a lot lately. Check out this round-up of the latest articles and podcasts about fentanyl, meth, xylazine, health hubs, and more! adai.uw.edu/adai-in-the-news…
ALT A hand holding a cell phone that reads NEWS in large letters at the top
Good information about the limited amount of #xylazine in WA State to date, even as we remain vigilant and work to address #fentanyl @adai_uw #NASEN #TacomaNeedleExchange
This quoted post is unavailable.
Caleb Banta-Green retweeted
Check out this great interview with ADAI/@UWPsychiatry Assistant Professor Mandy Owens, talking about her work on improving interactions between law enforcement and people who use drugs, medications for opioid use disorder in jail settings, and more! prainc.com/gains-qa-mandy-ow…
ALT SAMHSA's GAINS Center. Q&A with Dr. Mandy Owens, Assistant Professor, Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, University of Washington School of Medicine